Michael Scolaro

Michael Scolaro

Oct 08, 2017

Group 6 Copy 159
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

A Modification to Homeopathic Drug Carcinosin

Cancer is linked to genetic mutations in hosts who are already genetically unique, which can make it seem...

Personalized Cancer and Viral Therapy: Clostridium-based Cell Delivery System coupled to CRISPR/Cas9 Nanotherapeutic

One of the fundamental weaknesses in cancer treatment or any therapy based at the cellular level is entering...

Mosquitoes as Flying Syringes: The Solution to Rapid Zika Monitoring

Yes, mosquitoes are flying syringes! They sample human blood as a normal part of their life cycle. We can...

Backer Badge Funded